Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has a beta value of 1.19 and has seen 2.14 million shares traded in the last trading session. The company, currently valued at $129.79M, closed the last trade at $20.17 per share which meant it lost -$6.5 on the day or -24.37% during that session. The TNXP stock price is -5357.61% off its 52-week high price of $1100.80 and 66.48% above the 52-week low of $6.76. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.38 million shares traded. The 3-month trading volume is 1.66 million shares.
The consensus among analysts is that Tonix Pharmaceuticals Holding Corp (TNXP) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 5 have rated it as a Hold, with 4 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -3.09.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) trade information
Sporting -24.37% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the TNXP stock price touched $20.17 or saw a rise of 46.68%. Year-to-date, Tonix Pharmaceuticals Holding Corp shares have moved -38.84%, while the 5-day performance has seen it change -12.42%. Over the past 30 days, the shares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) have changed 146.58%. Short interest in the company has seen 0.88 million shares shorted with days to cover at 0.56.
Tonix Pharmaceuticals Holding Corp (TNXP) estimates and forecasts
The company’s shares have gained 53.27% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 9.97%.
1 analysts offering their estimates for the company have set an average revenue estimate of 2.6M for the current quarter. 1 have an estimated revenue figure of 2.8M for the next ending quarter. Year-ago sales stood 2.48M and 2.21M respectively for this quarter and the next, and analysts expect sales will grow by 4.75% for the current quarter and 9.97% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 46.06% over the past 5 years.
TNXP Dividends
Tonix Pharmaceuticals Holding Corp is expected to release its next earnings report on 2025-Mar-17 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s Major holders
Investors are also buoyed by the number of investors in a company, with Tonix Pharmaceuticals Holding Corp having a total of 35.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Total Market Index Fund . As of Jan 31, 2025 , the former fund manager holds about 16.00% shares in the company for having 1.03 shares of worth $20.76 million while later fund manager owns 401.61 shares of worth $8.1 million as of Jan 31, 2025 , which makes it owner of about 6.24% of company’s outstanding stock.
